Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2724 of 6351
-
New COPD rehab combines hospital and home exercises
Disease control Not yet recruitingThis study evaluates the effect of a structured three-month pulmonary rehabilitation (PR) program, delivered both in-hospital and at home, on exercise capacity, respiratory symptoms, and functional status in stable COPD patients.
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New custom pessary aims to solve fit problems for pelvic organ prolapse
Symptom relief Recruiting nowPelvic organ prolapse (POP) is a common health issue. It will impact about half of Canadian women over their lifetime. With POP, organs like the bladder, uterus, and bowel may push into the vagina. Women may experience urine leakage, physical discomfort, and embarrassment. Aside …
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Heart energy boost? MRI study tests new drug in thickened heart muscle
Knowledge-focused Not yet recruitingHypertrophic Cardiomyopathy (HCM) is the most common inherited heart condition, where the heart muscles can thicken to the point of obstructing blood flow out of the heart. This condition is associated with a chronic state of energy loss in the heart muscle. Till more recently, …
Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Heart-Saving hope: melatonin and vitamin d tested in breast cancer patients
Symptom relief Not yet recruitingThis study aims to assess the cardioprotective effect of melatonin and vitamin D in breast cancer patients who receive doxorubicin.
Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Common nausea pill may tame immunotherapy's harsh side effects in liver cancer
Symptom relief Recruiting nowThis study is a prospective, randomized, single-center randomized controlled clinical trial to investigate the safety and efficacy of ondansetron in reducing the toxicity associated with immune checkpoint inhibitor treatment. This study plans to enroll 134 patients with hepatocel…
Phase 2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
New hope for lung cancer patients: drug combo aims to stop chemo-radiation sickness
Symptom relief Not yet recruitingThis study aims to evaluate the efficacy and safety of a combination regimen based on Rolapitant Palonosetron injection for preventing nausea and vomiting induced by concurrent chemoradiotherapy in lung cancer patients. It will also analyze the differences in preventive efficacy …
Sponsor: Henan Cancer Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New strategy aims to tame treatment side effects in lung cancer patients
Symptom relief Not yet recruitingThis study aims to explore the clinical outcomes of Comprehensive Enhanced Preventive Management (CEPM) combined with an amivantamab-containing treatment regimen in Chinese patients with EGFR-mutated advanced NSCLC.
Phase 4 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Can your own blood cure your hives? new trial investigates
Disease control Not yet recruitingTo evaluate the efficacy of Autologous Whole Blood Therapy versus conventional treatment using fourfold dose of antihistamines in Autologus serum skin test (ASST) positive and negative Chronic Idiopathic Urticaria (CIU) patients and suggest its possible mechanism of action.
Phase 3 • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Heart rehab hope for rare amyloidosis patients
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if a structured cardiac rehabilitation program can help people with cardiac amyloidosis improve their ability to exercise and their quality of life. The main questions it aims to answer are: Does cardiac rehabilitation raise peak oxyge…
Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New diabetes pill shows promise for patients stuck on ozempic
Disease control Recruiting nowThis is a phase 2 randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes (T2D) not achieving glycemic targets despite Ozempic-based therapy.
Phase 2 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study tests suction tools to make kidney stone surgery safer
Disease control Not yet recruitingKidney stones are a common health problem and may recur frequently, which can affect quality of life and kidney function. Retrograde intrarenal surgery (RIRS) is a minimally invasive treatment used for renal stones, but treatment of medium-sized stones may be associated with long…
Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New leg therapy aims to get stroke patients back on their feet
Symptom relief Not yet recruitingThis study aims to investigate the effects of a proprioceptive neuromuscular facilitation (PNF)-based lower extremity rehabilitation program on balance, gait performance, functional independence, and quality of life in individuals with stroke. Stroke is a leading cause of long-t…
Sponsor: Istanbul Medipol University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New hope for Tick-Bite survivors: mast cell drugs aim to ease lingering symptoms
Symptom relief Not yet recruitingThis is a Phase II double-blinded study to assess the safety, tolerability, and feasibility of the mast cell stabilizing medications ketotifen and cromolyn compared to participants receiving standard of care treatment with fexofenadine alone in participants who have persistent sy…
Phase 2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
AI tool aims to spot head and neck cancer risk early
Knowledge-focused Recruiting nowThis study aims to develop and validate a clinical prediction model for the risk of head and neck cancerous lesions using deep learning combined with AI algorithms, based on multi-center clinical data.
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Scientists hunt for clues to chemo allergies in kids with leukemia
Knowledge-focused Not yet recruitingAcute lymphoblastic leukemia is a type of blood cancer that primarily affects children. Fortunately, current treatments are highly effective. One of the key drugs used is asparaginase, which works by depriving leukemic cells of a substance that is essential for their survival. H…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New drug trial aims to calm IBS-Related diarrhea and pain
Symptom relief Not yet recruitingIrritable bowel syndrome (IBS) tends to be a lifelong disorder and it is often frustrating to both patients and physicians. This study aim of improving symptom control, reducing healthcare burden and upgrading the quality of life of patient with diarrhea predominant IBS-D. Patie…
Phase 4 • Sponsor: Md. Aminul Islam • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Robot suit aims to steady aging and Parkinson's steps
Symptom relief Recruiting nowThis study will evaluate whether a wearable robotic exoskeleton can improve mobility, balance, and walking in healthy older adults and in individuals living with Parkinson's disease, populations at high risk of falls and mobility limitations. Participants will attend two laborato…
Sponsor: Centre intégré de santé et de services sociaux de l'Outaouais • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Experimental RNA vaccine takes on advanced lung cancer
Vaccine Recruiting nowThis is an open-label, single-arm, non-randomized, single-center, prospective phase 1 clinical trial. The study will evaluate the safety, tolerability, and preliminary antitumor activity of IMP3-saRNA (YMN-136) vaccine in patients with advanced non-small cell lung cancer. IMP3-s…
Phase 1 • Sponsor: West China Hospital • Aim: Vaccine
Last updated Jun 27, 2026 12:31 UTC
-
Heart rate clues could unmask hidden sleep apnea in hypertensive patients
Knowledge-focused Recruiting nowThis study aims to investigate the relationship between hypertension and obstructive sleep apnea (OSA) using heart rate variability (HRV) as a non-invasive biomarker of autonomic nervous system function. Hypertensive patients at high risk for OSA will undergo 24-hour Holter elec…
Sponsor: Kaohsiung Armed Forces General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Yoga in schools may ease exam jitters for teens
Symptom relief CompletedThis cluster randomized controlled trial evaluates the effects of a yoga therapy program grounded in the Neuman Systems Model on test anxiety, quality of life, and mindfulness among eighth-grade students aged 13-14 years in Denizli, Türkiye. The study was conducted with students …
Sponsor: Pamukkale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC